Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Transient infection of freshly isolated human colorectal tumor cells by reovirus T3D intermediate subviral particles

Abstract

Reovirus T3D preferentially kills tumor cells expressing Ras oncogenes and has shown great promise as an anticancer agent in various preclinical tumor models. Here, we investigated whether reovirus can infect and kill tumor cell cultures and tissue fragments isolated from resected human colorectal tumors, and whether this was affected by the presence of endogenous oncogenic KRAS. Tissue fragments and single-cell populations isolated from human colorectal tumor biopsies were infected with reovirus virions or with intermediate subviral particles (ISVPs). Reovirus virions were capable of infecting neither single-cell tumor cell populations nor small fragments of intact viable tumor tissue. However, infection of tumor cells with ISVPs resulted in transient viral protein synthesis, irrespective of the presence of oncogenic KRAS, but this did not lead to the production of infectious virus particles, and tumor cell viability was largely unaffected. ISVPs failed to infect intact tissue fragments. Thermolysin treatment of tumor tissue liberated single cells from the tissue and allowed infection with ISVPs, but this did not result in the production of infectious virus particles. Immunohistochemistry on tissue microarrays showed that junction adhesion molecule 1, the major cellular reovirus receptor, was improperly localized in the cytoplasm of colorectal tumor cells and was expressed at very low levels in liver metastases. This may contribute to the observed resistance of tumor cells to reovirus T3D virions. We conclude that infection of human colorectal tumor cells by reovirus T3D requires processing of virions to ISVPs, but that oncolysis is prevented by a tumor cell response that aborts viral protein synthesis and the generation of infectious viral particles, irrespective of KRAS mutation status.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Brummelkamp TR, Bernards R, Agami R . Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2002; 2: 243–247.

    Article  CAS  PubMed  Google Scholar 

  2. Shirasawa S, Furuse M, Yokoyama N, Sasazuki T . Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 1993; 260: 85–88.

    Article  CAS  PubMed  Google Scholar 

  3. Smakman N, Veenendaal LM, van Diest P, Bos R, Offringa R, Borel Rinkes IH et al. Dual effect of Kras(D12) knockdown on tumorigenesis: increased immune-mediated tumor clearance and abrogation of tumor malignancy. Oncogene 2005; 24: 8338–8342.

    Article  CAS  PubMed  Google Scholar 

  4. Clarke P, Debiasi RL, Goody R, Hoyt CC, Richardson-Burns S, Tyler KL . Mechanisms of reovirus-induced cell death and tissue injury: role of apoptosis and virus-induced perturbation of host-cell signaling and transcription factor activation. Viral Immunol 2005; 18: 89–115.

    Article  CAS  PubMed  Google Scholar 

  5. Smakman N, van den Wollenberg DJ, Borel Rinkes IH, Hoeben RC, Kranenburg O . Sensitization to apoptosis underlies KrasD12-dependent oncolysis of murine C26 colorectal carcinoma cells by reovirus T3D. J Virol 2005; 79: 14981–14985.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Smakman N, van den Wollenberg DJ, Elias SG, Sasazuki T, Shirasawa S, Hoeben RC et al. KRAS(D13) Promotes apoptosis of human colorectal tumor cells by ReovirusT3D and oxaliplatin but not by tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 2006; 66: 5403–5408.

    Article  CAS  PubMed  Google Scholar 

  7. Strong JE, Coffey MC, Tang D, Sabinin P, Lee PW . The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J 1998; 17: 3351–3362.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Coffey MC, Strong JE, Forsyth PA, Lee PW . Reovirus therapy of tumors with activated Ras pathway. Science 1998; 282: 1332–1334.

    Article  CAS  PubMed  Google Scholar 

  9. Hirasawa K, Nishikawa SG, Norman KL, Alain T, Kossakowska A, Lee PW . Oncolytic reovirus against ovarian and colon cancer. Cancer Res 2002; 62: 1696–1701.

    CAS  PubMed  Google Scholar 

  10. Hirasawa K, Nishikawa SG, Norman KL, Coffey MC, Thompson BG, Yoon CS et al. Systemic reovirus therapy of metastatic cancer in immune-competent mice. Cancer Res 2003; 63: 348–353.

    CAS  PubMed  Google Scholar 

  11. Norman KL, Coffey MC, Hirasawa K, Demetrick DJ, Nishikawa SG, Difrancesco LM et al. Reovirus oncolysis of human breast cancer. Hum Gene Ther 2002; 13: 641–652.

    Article  CAS  PubMed  Google Scholar 

  12. Smakman N, van der Bilt JD, van den Wollenberg DJ, Hoeben RC, Borel Rinkes IH, Kranenburg O . Immunosuppression promotes reovirus therapy of colorectal liver metastases. Cancer Gene Ther 2006; 13: 815–818.

    Article  CAS  PubMed  Google Scholar 

  13. Norman KL, Lee PW . Not all viruses are bad guys: the case for reovirus in cancer therapy. Drug Discov Today 2005; 10: 847–855.

    Article  CAS  PubMed  Google Scholar 

  14. Barton ES, Forrest JC, Connolly JL, Chappell JD, Liu Y, Schnell FJ et al. Junction adhesion molecule is a receptor for reovirus. Cell 2001; 104: 441–451.

    Article  CAS  PubMed  Google Scholar 

  15. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4: 844–847.

    Article  CAS  PubMed  Google Scholar 

  16. Perreault N, Jean-Francois B . Use of the dissociating enzyme thermolysin to generate viable human normal intestinal epithelial cell cultures. Exp Cell Res 1996; 224: 354–364.

    Article  CAS  PubMed  Google Scholar 

  17. Nibert ML, Chappell JD, Dermody TS . Infectious subvirion particles of reovirus type 3 Dearing exhibit a loss in infectivity and contain a cleaved sigma 1 protein. J Virol 1995; 69: 5057–5067.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Tyler KL, Clarke P, Debiasi RL, Kominsky D, Poggioli GJ . Reoviruses and the host cell. Trends Microbiol 2001; 9: 560–564.

    Article  CAS  PubMed  Google Scholar 

  19. Chappell JD, Gunn VL, Wetzel JD, Baer GS, Dermody TS . Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein sigma1. J Virol 1997; 71: 1834–1841.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Chappell JD, Duong JL, Wright BW, Dermody TS . Identification of carbohydrate-binding domains in the attachment proteins of type 1 and type 3 reoviruses. J Virol 2000; 74: 8472–8479.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Connolly JL, Barton ES, Dermody TS . Reovirus binding to cell surface sialic acid potentiates virus-induced apoptosis. J Virol 2001; 75: 4029–4039.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Byrd JC, Bresalier RS . Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 2004; 23: 77–99.

    Article  CAS  PubMed  Google Scholar 

  23. Hollingsworth MA, Swanson BJ . Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 2004; 4: 45–60.

    Article  CAS  PubMed  Google Scholar 

  24. Helander A, Silvey KJ, Mantis NJ, Hutchings AB, Chandran K, Lucas WT et al. The viral sigma1 protein and glycoconjugates containing alpha2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces. J Virol 2003; 77: 7964–7977.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Bisaillon M, Senechal S, Bernier L, Lemay G . A glycosyl hydrolase activity of mammalian reovirus sigma1 protein can contribute to viral infection through a mucus layer. J Mol Biol 1999; 286: 759–773.

    Article  CAS  PubMed  Google Scholar 

  26. Marcato P, Shmulevitz M, Pan D, Stolz D, Lee PW . Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release. Mol Ther 2007; 15: 1522–1530.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all the patients for their willingness to take part in this research project. We also give special thanks to Dr A Pronk and Dr J van Gorp of the Diaconessen Hospital Utrecht for providing us with surgical specimens, and Dr E Cuppen from the Hubrecht Laboratory (Utrecht, The Netherlands) for high-throughput resequencing of tumor samples (supported by an investment grant (NWO-Groot) from the Netherlands Research Organization). WJvH and LMV were supported by the Dutch Organization for health research and innovation (ZON-Mw 920-03-281 and 920-03-382). NS was supported by a grant from the Wijnand M PON Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O Kranenburg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Houdt, W., Smakman, N., van den Wollenberg, D. et al. Transient infection of freshly isolated human colorectal tumor cells by reovirus T3D intermediate subviral particles. Cancer Gene Ther 15, 284–292 (2008). https://doi.org/10.1038/cgt.2008.2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2008.2

Keywords

This article is cited by

Search

Quick links